Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin and Hydroxychloroquine for COVID-19
NCT05026801Phase 3Withdrawn
- Sponsor
- Iterum Therapeutics plc
- Start
- Feb 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin, hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Iterum Therapeutics plc. Planned start Feb 2021; status: withdrawn.
02
Drugs
azithromycinhydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05026801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05026801.